Global Medical REIT Stock Price, News & Analysis (NYSE:GMRE)

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" GMRE shares.
View GMRE analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued 1 year target prices for Global Medical REIT's shares. Their GMRE share price targets range from $11.00 to $12.50. On average, they predict the company's stock price to reach $11.50 in the next twelve months. This suggests a possible upside of 11.2% from the stock's current price.
View analysts price targets for GMRE or view top-rated stocks among Wall Street analysts.

Global Medical REIT's stock was trading at $9.48 at the beginning of 2023. Since then, GMRE stock has increased by 9.1% and is now trading at $10.34.
View the best growth stocks for 2023 here.

Global Medical REIT saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 1,310,000 shares, an increase of 13.9% from the October 31st total of 1,150,000 shares. Based on an average trading volume of 289,600 shares, the short-interest ratio is currently 4.5 days.
View Global Medical REIT's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Tuesday, February 27th 2024.
View our GMRE earnings forecast.

Global Medical REIT Inc. (NYSE:GMRE) posted its quarterly earnings data on Wednesday, May, 4th. The company reported $0.04 earnings per share for the quarter, missing analysts' consensus estimates of $0.23 by $0.19. Global Medical REIT had a trailing twelve-month return on equity of 3.10% and a net margin of 12.09%. During the same period last year, the business posted $0.24 EPS.

Global Medical REIT declared a quarterly dividend on Friday, September 8th. Stockholders of record on Friday, September 22nd will be paid a dividend of $0.21 per share on Tuesday, October 10th. This represents a $0.84 annualized dividend and a yield of 8.12%. The ex-dividend date is Thursday, September 21st.
Read our dividend analysis for GMRE.

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 8.12%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 336.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 95.45% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

ETFs with the largest weight of Global Medical REIT (NYSE:GMRE) stock in their portfolio include Invesco KBW Premium Yield Equity REIT ETF (KBWY), ALPS REIT Dividend Dogs ETF (RDOG), Hoya Capital High Dividend Yield ETF (RIET), Sound Enhanced Fixed Income ETF (FXED), Sound Enhanced Fixed Income ETF (SDEF) and Arrow Dow Jones Global Yield ETF (GYLD).iShares Residential and Multisector Real Estate ETF (REZ).

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include Principal Financial Group (PFG), INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

(GMRE) raised $130 million in an initial public offering on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer acted as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

Global Medical REIT's stock is owned by many different institutional and retail investors. Top institutional shareholders include Brown Advisory Inc. (2.17%), Royal Bank of Canada (1.86%), Invesco Ltd. (1.57%), Sound Income Strategies LLC (1.39%), State of New Jersey Common Pension Fund D (1.33%) and Stifel Financial Corp (1.28%). Insiders that own company stock include Henry Cole and Jeffrey Busch.
View institutional ownership trends.

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.